NIBEC Co., Ltd.

A138610

KR7138610001

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-12 EDT			5-day change	1st Jan Change
16,670 ^KRW	-1.24%		-4.20%	-23.00%

2022	NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	CI
2022	NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	CI

NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors

November 21, 2022

On November 22, 2022, NIBEC Co., Ltd. closed the transaction.

Latest news about NIBEC Co., Ltd.

NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors	22-11-21	CI
NIBEC Co., Ltd. announced that it expects to receive KRW 25 billion in funding from a group of investors	22-11-17	CI
NIBEC Co., Ltd.(KOSDAQ:A138610) added to S&P Global BMI Index	21-09-20	CI
NIBEC Co., Ltd. announced that it has received KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	20-12-27	CI
NIBEC Co., Ltd. announced that it expects to receive KRW 10 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm	20-12-22	CI
NIBEC Co., Ltd. announced that it has received KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	17-12-25	CI
NIBEC Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Korea Asset Investment Securities Co., Ltd.	17-12-21	CI
NIBEC Co. Ltd. announced that it has received KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	16-03-30	CI
NIBEC Co. Ltd. announced that it expects to receive KRW 6 billion in funding from Hyundai Venture Investment Corp., Daedong Investment Co., Ltd., and other investors.	16-03-29	CI
NIBEC Co. Ltd. announced that it has received KRW 2 billion in funding.	15-03-01	CI
NIBEC Co. Ltd. announced that it expects to receive KRW 2 billion in funding.	15-02-25	CI

NIBEC Co., Ltd. is a Korea-based company specialized in the manufacturing of dental medical products and supplies. The Company provides two main categories of products: dental health products and regeneration biomaterials. The dental health products consist of tooth whitening products under the brand name Blanc Tis; remedies for sensitive teeth under the brand name SensBlok, and dental conditioners under the brand name Clinplant. The regeneration biomaterials include bone graft materials under the brand name OCS-B, OCS-H and OCS-Collagen, as well as bone regenerative powders, bone morphogenetic materials, peptide bone powders and injectable gels. It also provides cosmetics under the brand name Skin Aropa. The Company distributes its products within domestic market and to overseas markets.

Sector

Biotechnology & Medical Research

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Medical Devices

	1st Jan change	Capi.
NIBEC CO., LTD.	-23.00%	126M
MIMEDX GROUP, INC.	-9.92%	1.1B
COLLPLANT BIOTECHNOLOGIES LTD.	+2.74%	75.91M
KIM FOREST ENTERPRISE CO., LTD.	+2.44%	60.02M
BONUS BIOGROUP LTD.	-2.99%	50.76M

Bio Medical Devices

NIBEC Co., Ltd.

Equities

A138610

KR7138610001

Biotechnology & Medical Research

NIBEC Co., Ltd. announced that it has received KRW 25 billion in funding from a group of investors

Latest news about NIBEC Co., Ltd.

Chart NIBEC Co., Ltd.

Company Profile

Income Statement Evolution

Sector Bio Medical Devices